(Reuters Health) – In people at high risk for type 1 diabetes, 14 days of therapy with the experimental drug teplizumab delayed development of the disease by a year or more, according to results from a mid-stage study presented Sunday. The 76 study participant... More »
(Reuters Health) – If you’re talking vitamin D and expecting it to lower your risk of getting type 2 diabetes when you get older, it’s time to lower your expectations. A new study, the largest of its kind, has found that taking 4000 international units (IU) pe... More »
SHANGHAI (Reuters) – The Chinese government on Thursday ordered a temporary halt to research activities for people involved in the editing of human genes, after a Chinese scientist said he had edited the genes of twin babies. Scientist He Jiankui said this wee... More »
By Andrew M. SeamanReuters Health – Men can safely take a pill that protects against the virus that causes AIDS when they need it, instead of every More »
FILE PHOTO – Then Deputy Health Minister Huang Jiefu speaks during a group session of the Chinese People’s Political Consultative Conference (CPPCC) in Beijing March 10, 2011. REUTERS/Stringer/File Photo Beijing’s top official on transplants said on Tuesday Be... More »
By Andrew M. Seaman(Reuters Health) – The quantity and quality of media children and teens consume should change with their age, according to new gu More »
